Login | Register

Thiazolidinedione Raises Diabetic Macular Edema

According to a report published Online First in Archives of Internal Medicine, glucose-lowering thiazolidinedione drug therapies in patients with Type 2 diabetes seem to be linked to a higher risk of diabetic macular edema (DME) after 1 and 10-year follow up. DME is a complication that may affect a person's vision...

Read More

Leave a Reply

Your email address will not be published. Required fields are marked *